LOC105372685 variant X1: A potential drug target for hypertension and inflammation

LOC105372685 variant X1: A potential drug target for hypertension and inflammation

LOC105372685 (LOC105372685 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play an important role in cellular signaling.

LOC105372685 variant X1 is a specific variant of the LOC105372685 gene, which is located on chromosome 10 (10q24). This gene is responsible for the production of a protein that is known as the activator of the GPCR signaling pathway. This protein has been shown to play a role in the regulation of a variety of physiological processes in the body, including blood pressure, heart rate, and inflammation.

One of the reasons why LOC105372685 variant X1 is of interest as a drug target is its role in the regulation of blood pressure. High blood pressure, also known as hypertension, is a serious health condition that can lead to a wide range of health problems, including heart disease, stroke, and kidney damage. It is estimated that approximately 90 million Americans have high blood pressure, and this number is expected to increase as the population ages.

Studies have shown that LOC105372685 variant X1 plays a role in the regulation of blood pressure by controlling the activity of GPCR signaling pathway. This protein has been shown to interact with several different GPCRs, including the beta-2 adrenergic receptor (??2AR), which is a GPCR that is involved in the regulation of heart rate and blood pressure.

In addition to its role in the regulation of blood pressure, LOC105372685 variant X1 is also of interest as a potential biomarker for the diagnosis and monitoring of hypertension. This is because it is highly expressed in the brain, heart, and blood vessels, which are all areas of the body that are known to be involved in the regulation of blood pressure.

Another potential use for LOC105372685 variant X1 as a drug target is its role in the regulation of inflammation. Chronic inflammation is a major risk factor for a wide range of diseases, including heart disease and diabetes. It is estimated that approximately 60 million Americans have chronic inflammation, and this number is expected to increase as the population ages.

Studies have shown that LOC105372685 variant X1 plays a role in the regulation of inflammation by controlling the activity of several different GPCRs, including the nuclear factor kappa B (NF-kappa-B) signaling pathway. This protein has been shown to interact with several different GPCRs, including the NF-kappa-B receptor (NF-kappa-B), which is involved in the regulation of inflammation.

In conclusion, LOC105372685 variant X1 is a protein that is expressed in various tissues of the body and is involved in the regulation of several important physiological processes in the body. The specific variant of this gene that is of interest as a drug target is LOC105372685 variant X1, which is involved in the regulation of blood pressure, heart rate, and inflammation. Further research is needed to fully understand the role of LOC105372685 variant X1 in these processes and to develop effective treatments for these conditions.

Protein Name: Uncharacterized LOC105372685

The "LOC105372685 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372685 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020